AngioDynamics (NASDAQ:ANGO) Issues Earnings Results

AngioDynamics (NASDAQ:ANGO) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07, RTT News reports. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS.

AngioDynamics Stock Performance

NASDAQ ANGO opened at $9.40 on Wednesday. The firm’s fifty day moving average is $7.82 and its two-hundred day moving average is $7.27. AngioDynamics has a one year low of $5.26 and a one year high of $9.63. The firm has a market cap of $381.96 million, a PE ratio of -1.54 and a beta of 0.59.

Analyst Upgrades and Downgrades

Several analysts recently commented on ANGO shares. HC Wainwright reissued a “buy” rating and issued a $14.00 price objective on shares of AngioDynamics in a research note on Tuesday, December 10th. Canaccord Genuity Group dropped their price objective on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, October 4th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.